Farnesyl-transferase inhibitors show synergistic anticancer effects in combination with novel KRAS-G12C inhibitors.

Marcell BaranyiEszter MolnárLuca HegedűsZsófia GábrielFlóra Gréta PetényiFanni BordásVioletta LénerIvan RanđelovićMihály CserepesJózsef TóváriBalazs HegedüsJózsef Tímár

Published in: British journal of cancer (2024)

Our findings warrant the clinical exploration of KRAS-G12C inhibitors in combination with farnesyl-transferase inhibitors.

Keyphrases

drug delivery